CN107823634A - 基于海洋多糖的治疗骨质疏松药物 - Google Patents

基于海洋多糖的治疗骨质疏松药物 Download PDF

Info

Publication number
CN107823634A
CN107823634A CN201711386030.0A CN201711386030A CN107823634A CN 107823634 A CN107823634 A CN 107823634A CN 201711386030 A CN201711386030 A CN 201711386030A CN 107823634 A CN107823634 A CN 107823634A
Authority
CN
China
Prior art keywords
parts
treating osteoporosis
extract
medicine
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711386030.0A
Other languages
English (en)
Inventor
包卫洋
左爱华
杨大苹
王祖哲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Deep Blue Peptide Technology Research And Development Co Ltd
Original Assignee
Dalian Deep Blue Peptide Technology Research And Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Deep Blue Peptide Technology Research And Development Co Ltd filed Critical Dalian Deep Blue Peptide Technology Research And Development Co Ltd
Priority to CN201711386030.0A priority Critical patent/CN107823634A/zh
Publication of CN107823634A publication Critical patent/CN107823634A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486Millettia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供了一种基于海洋多糖的治疗骨质疏松药物,是由以下的重量份的原料组成:海参糖肽8‑10份、海藻多糖6‑8份、氨基葡萄糖1.5‑2.0 g、鱼胶原蛋白肽6‑8份、杜仲提取物4‑5份、淫羊藿提取物3‑4份、鸡血藤提取物6‑8份、熟地提取物3‑4份、枸杞提取物5‑7份,该组方通过补充骨关节所需的胶原蛋白、多肽、多糖、钙等营养物质,起到消除关节炎症,减轻疼痛,修复受损的关节软骨并促进再生,提高免疫力等作用,同时结合中医理论活血通络、补益肝肾、强筋壮骨,共同达到从根本上治疗骨质疏松的目的。

Description

基于海洋多糖的治疗骨质疏松药物
技术领域
本发明属于医药领域,具体涉及治疗骨质疏松的药物。
背景技术
骨质疏松是由多种原因引起的骨关节疾病,症状多表现为骨骼疼痛、活动受限、身长变短、驼背,易于骨折。分为原发性和继发性骨质疏松,多以老年性骨质疏松和绝经后骨质疏松最为常见,老年人和女性为多发人群,随着社会老龄化的加剧,患有骨质疏松的人群也呈逐渐上升趋势。
目前用于治疗和阻止骨质疏松症发展的药物有两大类,第一类为抑制骨吸收药,包括钙剂、维生素D、降钙素、二磷酸盐、雌激素以及异黄酮;第二类为促进骨性成药,包括氟化物、合成类固醇、甲状旁腺激素以及异黄酮,这些西药虽有一定疗效,但副作用大,费用昂贵,且治标不治本,而且需要长期服用,且未能从根本上改善骨关节的炎症及病变,同时也未能从病因入手进行彻底的治疗,因此迫切需要研发一种治疗骨质疏松的有效组方。
发明内容
为解决上述存在的问题,本发明提供了一种基于海洋多糖的治疗骨质疏松药物,结合海洋蛋白及多糖的独特功效及中医理论,此方既可以针对骨质疏松引起的骨关节问题进行治疗,也可以从中医理论的水平对引起骨质疏松的病因进行治疗,从而对骨质疏松和多种骨关节疾病起到显著的治疗作用,从根本上解决病患的痛苦。。
本发明的具体技术方案是:基于海洋多糖的治疗骨质疏松药物,由以下的重量份的料组成:海参糖肽8-10份、海藻多糖6-8份、氨基葡萄糖1.5-2.0 g、鱼胶原蛋白肽6-8份、杜仲提取物4-5份、淫羊藿提取物3-4份、鸡血藤提取物6-8份、熟地提取物3-4份、枸杞提取物5-7份。
所述药物可根据需要,制成冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。
各以上原料具有以下功效:
海参糖肽含有海参多糖和海参肽,其中海参多糖一种为海参糖胺聚糖或粘多糖,一种为海参岩藻多糖,具有抗凝抗血栓,促进纤溶,降血脂,抗肿瘤等多种生理活性,其中糖胺聚糖具有很强的亲水性,以及粘滞性,附在关节面上具有润滑和保护作用,它的一个类别为硫酸软骨素,是治疗关节疾病的药物,与氨基葡萄糖配合使用,具有止痛,促进软骨再生的功效,能从根本改善关节问题。海参肽是有海参蛋白经酶解获得小分子多肽,能够补充人体所需要的活性肽,具有抗疲劳,提高免疫力的作用
海藻多糖具有抗凝抗血栓、降血脂、抗菌抗炎、提高免疫力等作用,其中褐藻多糖硫酸酯含有大量硫酸基结合的多糖,而人体软骨对氨糖的吸收主要是靠“硫酸根”介导的起作用的,同时褐藻多糖硫酸酯对肾脏疾病有显著的疗效,能调节并改善肾脏功能。
氨基葡萄糖是形成软骨细胞的重要营养素之一,也是软骨基质和关节液的基本成分,广泛用于骨关节疾病的预防和治疗,具有修复软骨,修复免疫环节的作用,氨糖常与胶原蛋白、硫酸软骨素协同对抗骨关节炎,效果显著。
鱼胶原蛋白肽通过胶原蛋白水解获得,比胶原蛋白吸收更好更快,而胶原蛋白是人体骨骼,尤其是软骨组织中的重要组成成分,如果缺少胶原蛋白,补充再多的钙质也无法防止骨质疏松。
杜仲提取物:补肝肾、强筋骨、补中气,益精气,主治腰膝痛
淫羊藿提取物:补命门、益精气、强筋骨、补肾壮阳之要药,能温肾壮阳、强筋骨、祛风湿。
鸡血藤提取物:补血行血,通经活络,可治疗风湿所致的腰膝关节疼痛、风湿痹痛、肢体麻木
枸杞提取物:滋补肝肾,益精明目,常用于肝肾不足的腰膝酸软、头晕目眩、视物昏花。
熟地提取物:滋阴补血、益精填髓,常用于肾虚所致的腰膝酸软等症。
本发明的独特之处在于:标本兼治,海参糖肽、海藻多糖、氨基葡萄糖、鱼胶原蛋白肽提供人体骨关节所需的胶原蛋白、活性肽、多糖、钙等多种营养元素,既能够抑制骨关节炎症,又能修复促进骨关节的修复和再生,提高人们免疫力,从而起到维护骨骼健康,增加骨密度的作用。而依据中医理论,肾为先天之本,肾藏精,主骨生髓,骨质疏松病在骨,根在肾,皆有肝肾亏虚引起,所以采用杜仲、淫羊藿、枸杞、熟地提取物补肝肾、强筋骨,滋阴补血、益精填髓,同时配合鸡血藤提取物舒筋活络、活血化瘀之功效,最终使得周遭血得活、脉得通。该组方即针对骨关节的损伤进行修复再生,又根据中医理论,补益肝肾,强筋健骨,各种药物协同作用,组方科学,效果显著。
具体实施方式
下面结合实施例对本发明做进一步详细说明,但不是对本发明的限制。
实施例1:一种基于海洋多糖的治疗骨质疏松药物,由以下重量份的原料组成:海参糖肽10份、海藻多糖8份、氨基葡萄糖1.8 g、鱼胶原蛋白肽6份、杜仲提取物5份、淫羊藿提取物4份、鸡血藤提取物8份、熟地提取物3份、枸杞提取物7份。
实施例2病例:
(1)陈某某,男,60岁。腰部疼痛,膝关节疼痛怕冷,行走不便,易发生习惯性踝骨骨折,服用钙补充剂无效,多方治疗不得好转,服用本组方药物治疗半年后,症状消失,无任何身体不适。
(2)姜某某,女,65岁,体质虚弱,浑身无力,呼吸不畅、颈椎疼痛,腰部酸软,弯腰驼背,多方治疗无效,经服用本方一个月后上述症状明显减轻,继续服用本方八个月后,身体恢复正常,虽仍驼背,但无身体疼痛,体力增加,无生活不便。

Claims (2)

1.一种基于海洋多糖的治疗骨质疏松药物,其特征在于:由下列重量份的原料组成:是由以下的重量份的原料组成:海参糖肽8-10份、海藻多糖6-8份、氨基葡萄糖1.5-2.0 g、鱼胶原蛋白肽6-8份、杜仲提取物4-5份、淫羊藿提取物3-4份、鸡血藤提取物6-8份、熟地提取物3-4份、枸杞提取物5-7份。
2.基于权利1所要求的一种基于海洋多糖的治疗骨质疏松药物,其特征在于:根据需要制成冲剂、颗粒剂、散剂、胶囊剂、水丸剂或片剂剂型。
CN201711386030.0A 2017-12-20 2017-12-20 基于海洋多糖的治疗骨质疏松药物 Pending CN107823634A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711386030.0A CN107823634A (zh) 2017-12-20 2017-12-20 基于海洋多糖的治疗骨质疏松药物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711386030.0A CN107823634A (zh) 2017-12-20 2017-12-20 基于海洋多糖的治疗骨质疏松药物

Publications (1)

Publication Number Publication Date
CN107823634A true CN107823634A (zh) 2018-03-23

Family

ID=61645094

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711386030.0A Pending CN107823634A (zh) 2017-12-20 2017-12-20 基于海洋多糖的治疗骨质疏松药物

Country Status (1)

Country Link
CN (1) CN107823634A (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108853486A (zh) * 2018-05-04 2018-11-23 湖北和格复合骨胶原生物科技有限公司 一种具有增强免疫力功能的配方产品
CN109170454A (zh) * 2018-08-04 2019-01-11 安徽全康药业有限公司 一种防骨质疏松氨糖高钙固体饮料
CN114522183A (zh) * 2022-01-24 2022-05-24 江南大学 一种增加骨密度的海参提取物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108853486A (zh) * 2018-05-04 2018-11-23 湖北和格复合骨胶原生物科技有限公司 一种具有增强免疫力功能的配方产品
CN108853486B (zh) * 2018-05-04 2022-03-04 湖北和格复合骨胶原生物科技有限公司 一种具有增强免疫力功能的配方产品
CN109170454A (zh) * 2018-08-04 2019-01-11 安徽全康药业有限公司 一种防骨质疏松氨糖高钙固体饮料
CN114522183A (zh) * 2022-01-24 2022-05-24 江南大学 一种增加骨密度的海参提取物

Similar Documents

Publication Publication Date Title
WO2015187097A1 (en) Composition for prevention and treatment of joint pain and the method of preparation thereof
CN107823634A (zh) 基于海洋多糖的治疗骨质疏松药物
CN102920876B (zh) 一种治疗膝关节骨性关节炎的外敷中药组合物
CN100336527C (zh) 一种治疗颈椎病的药物
CN104721426A (zh) 一种促进骨折愈合的中药组合物
CN107184689A (zh) 一种治疗骨关节和肌肉酸疼的药酒及其制备方法
CN105250392A (zh) 一种治疗骨关节炎的中药组合物
CN102579700A (zh) 一种治疗关节炎的药酒
CN103301215B (zh) 一种治疗骨质疾病的药物组合物及其制备方法与用途
CN106728002A (zh) 一种治疗跌打损伤的药酒
CN104826095B (zh) 一种软骨素联产蛋白粉及其生产方法和应用
CN104324319A (zh) 一种促进骨关节健康的保健品
CN104352907A (zh) 一种治疗慢性痛风性关节炎的中药组合物
CN102258762B (zh) 一种消肿止痛的药物组合物及其制剂和应用
CN102805803B (zh) 一种治疗类风湿性关节炎的中药
CN101690750B (zh) 治疗骨质增生的外用药物
CN102343066B (zh) 一种治疗骨质增生的药物组合物及其制备方法
CN108619448A (zh) 一种治疗骨质增生症的膏药及其制备方法
CN102000268B (zh) 一种治疗风湿类风湿病的中药口服制剂
CN106421098B (zh) 治疗多种骨病的外用中药组合物
CN104398596A (zh) 一种治疗口腔溃疡的中药配方
CN102961520B (zh) 一种治疗关节炎的药物组合物及其制备方法
CN103861039A (zh) 一种接骨药及制备方法
CN105582084A (zh) 一种治疗颈、腰椎病的中药配方
CN107802693A (zh) 治疗跌打损伤及其后遗症的外用青草药组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180323